Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Nov;80(5):1466-71.
doi: 10.1172/JCI113227.

Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics

Affiliations

Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics

H C Porchet et al. J Clin Invest. 1987 Nov.

Abstract

Persons exposed to nicotine develop tolerance to many of its effects. When heart rate and forearm venous blood concentration are plotted against time after intravenous administration of nicotine, a greater increase in heart rate is seen for a given nicotine concentration during the rising phase of nicotine concentrations than during the decreasing phase. This could be due to acute tolerance or to more rapid distribution of drug to effect site (brain) than to venous blood. To distinguish between these possibilities, six rabbits were given nicotine intravenously. Blood samples were taken from the internal jugular vein (reflecting brain concentration), and the femoral vein and artery. Brain concentrations peaked before femoral venous concentrations. Seven men received intravenous infusions of nicotine. Peripheral venous blood concentrations and cardiovascular responses were measured. Heart rate peaked before venous concentrations. A physiological kinetic model, fit to the rabbit data, was scaled to humans and used to predict "brain" concentrations in them. Heart rate and predicted brain concentrations peaked simultaneously. We conclude that the rapid development of tolerance to the cardioaccelerating effect of nicotine can be attributed, at least in part, to its distribution kinetics.

PubMed Disclaimer

References

    1. Am Heart J. 1985 Jul;110(1 Pt 2):224-32 - PubMed
    1. J Pharmacokinet Biopharm. 1984 Oct;12(5):545-58 - PubMed
    1. Pharmacol Rev. 1983 Mar;35(1):5-32 - PubMed
    1. Am J Med. 1983 Jun 27;74(6B):73-84 - PubMed
    1. Clin Pharmacol Ther. 1987 Apr;41(4):474-9 - PubMed

Publication types